The effects of chlorpromazine and Lorazepam on abnormal antisaccade and no-saccade distractibiiity

Biological Psychiatry

Volumn 44, Issue 8, 1998, Pages 709-715

  Green, Jonathan F ^a   King, David J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Abnormal saccadic distractibility; Antisaccades; Chlorpromazine; Lorazepam; Saccadic eye movements; Schizophrenia

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; LORAZEPAM;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FRONTAL CORTEX; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; SCHIZOPHRENIA; SCORING SYSTEM; SEDATION;

ADULT; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; ATTENTION; CHLORPROMAZINE; FRONTAL LOBE; HUMANS; LORAZEPAM; MALE; SACCADES;

EID: 0032532180     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00452-6     Document Type: Article

References (28)

1. Anderson T.J., Jenkins I.H., Brooks D.J., Hawken M.B., Frackowiak R.S.J., Kennard C. Cortical control of saccades and fixation in man - A PET study. Brain. 117:1994;1073-1084.
2. Ball D.M., Glue P., Wilson S., Nutt D.J. Pharmacology of saccadic eye movements in man 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil . Psychopharmacology. 105:1991;361-367.
3. Crawford T.J., Haeger B., Kennard C., Reveley M.A., Henderson L. Saccadic abnormalities in psychotic patients I. Neuroleptic free psychotic patients . Psychol Med. 25:1995;461-471.
4. Crawford T.J., Haeger B., Kennard C., Reveley M.A., Henderson L. Saccadic abnormalities in psychotic patients II. The role of neuroleptic treatment . Psychol Med. 25:1995;473-483.
5. Fukushima J., Fukushima K., Chiba T., Tanaka S., Yamashita I., Kato M. Disturbances of voluntary control of saccadic eye movements in schizophrenic patients. Biol Psychiatry. 23:1988;670-677.
6. Fukushima J., Morita N., Fukushima K., Chiba T., Tanaka S., Yamashita I. Voluntary control of saccadic eye movements in patients with schizophrenic and affective disorders. J Psychiatr Res. 24:1990;9-24.
7. Fukushima J., Fukushima K., Miyasaka K., Yamashita I. Voluntary control of saccadic eye movement in patients with frontal cortical lesions and parkinsonian patients in comparison with that in schizophrenics. Biol Psychiatry. 36:1994;21-30.
8. Glue P. The pharmacology of saccadic eye movements. J Psychopharmacol. 5:1991;377-387.
9. Green J.F., McElholm A., King D.J. A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam. Psychopharmacology. 128:1996;67-73.
10. Griffiths A.N., Marshall R.W., Richens A. Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance. Br J Clin Pharmacol. 18:(suppl 1):1984;73S-82S.
11. Guitton D., Buchtal H.A., Douglas R.M. Frontal lobe lesions in man cause difficulties in suppressing reflexive glances and in generating goal directed saccades. Exp Brain Res. 58:1985;455-474.
12. Hikosaka O., Wurtz R.H. Modification of saccadic eye movements by GABA-related substances I. Effect of muscimol and bicuculline in monkey superior colliculus . J Neurophysiol. 53:1985;266-291.
13. Kennard C., Crawford T.J., Henderson L. A pathophysiological approach to saccadic eye movements in neurological and psychiatric disease. J Neurol Neurosurg Psychiatry. 57:1994;881-885.
14. King D.J. Measures of neuroleptic effects on cognition and psychomotor performance in healthy volunteers. Hindmarch I., Stonier P. Human Psychopharmacology. vol 4:1993;195-209 Wiley, Chichester, UK.
15. King D.J. Psychomotor impairment and cognitive disturbances induced by neuroleptics. Acta Psychiatr Scand. 89:1994;53-58.
16. Lasker A.G., Zee D.S., Hain T.C., Folstein S.E., Singer H.S. Saccades in Huntington's disease Initiation defects and distractibility . Neurology. 37:1987;364-370.
17. Levin S. Frontal lobe dysfunctions in schizophrenia 1. Eye movement impairments . J Psychiatr Res. 18:1984;27-55.
18. Levin S. Frontal lobe dysfunctions in schizophrenia 2. Impairments of psychological and brain functions . J Psychiatr Res. 18:1984;57-72.
19. Marshall R.W., Griffiths A.N., Richens A. A microcomputer system to assess CNS depression from the analysis of the dynamics of saccadic eye movements. Br J Clin Pharmacol. 20:1985;304-305.
20. McDowell J.E., Clementz B.A. The effect of fixation condition manipulations on antisaccade performance in schizophrenia Studies of diagnostic specificity . Exp Brain Res. 115:1997;333-344.
21. Norris H. The action of sedatives on brainstem oculomotor systems in man. Neuropharmacology. 10:1971;181-191.
22. O'Driscoll G.A., Alpert N.M., Matthysse S.W., Levy D.L., Rauch S.L., Holzman P.S. Functional neuroanatomy of antisaccade eye movements investigated with positron emission tomography. Proc Natl Acad Sci USA. 92:1995;925-929.
23. Pierrot-Deseilligny C., Rivaud S., Pillon B., Fournier E., Agid Y. Lateral visually-guided saccades in progressive supranuclear palsy. Brain. 112:1989;471-487.
24. Pierrot-Deseilligny C., Rivaud S., Gaymard B., Agid Y. Cortical control of reflexive visually-guided saccades. Brain. 114:1991;1473-1485.
25. Simms M.G.N., Patel J.K.M., Dursun S.M., Burke J.G., Reveley M.A. The effects of risperidone and typical antipsychotic drugs on the functional state of the frontal-cortical-striatal network in schizophrenia. J Psychopharmacol. 10:1996;A4.
26. Strassman A., Highstein S.M., McRea R.A. Anatomy and physiology of saccadic burst neurons in the alert squirrel monkey I. Excitatory burst neurons . J Comp Neurol. 249:1986;337-357.
27. Sweeney J.A., Mintun M.A., Kwee S., Wiseman M.B., Brown D.I., Rosenberg D.R., et al. Positron emission tomography study of voluntary saccadic eye movements and spatial working memory. J Neurophysiol. 75:1996;454-468.
28. Thaker G.K., Nguyen J.A., Tamminga C.A. Increased saccadic distractibility in tardive dyskinesia Functional evidence for subcortical GABA dysfunction . Biol Psychiatry. 25:1989;49-59.